Visfatin and Retinol Binding Protein-4 in Young-Onset Type 2 Diabetes Mellitus

• Published in: Medicina (Kaunas, Lithuania) Vol. 59; no. 7; p. 1278
• Main Authors: Huang, Ya-Li, Chen, Yen-Lin, Lin, Jiunn-Diann, Pei, Dee, Pitrone, Pietro, Chen, Jin-Shuen, Wu, Chung-Ze
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.07.2023; MDPI
• Subjects: Atherosclerosis; Binding proteins; Blood pressure; Body fat; Body mass index; Cardiovascular disease; Dextrose; Diabetes; Glucose; Glucose metabolism; Inflammation; Insulin resistance; Metabolic syndrome; Obesity; old diabetes mellitus; Ovaries; Physiological aspects; Polycystic ovary syndrome; Protein binding; Proteins; Regression analysis; Retinoids; retinol binding protein 4; Statistical analysis; Type 2 diabetes; visfatin; young diabetes mellitus; Taiwan; United States > US; metabolic syndrome; old diabetes mellitus; retinol binding protein 4; young diabetes mellitus; visfatin
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina59071278

: The prevalence of type 2 diabetes mellitus in adolescents has increased rapidly in recent decades. However, the role of adipokines on pathophysiology in young-onset type 2 diabetes mellitus (YDM) is not clear. In this article, we explored the relationships between the adipokines (visfatin and retinol binding protein 4 (RBP4)) and metabolic syndrome (MetS) components in both YDM and late-onset type 2 diabetes mellitus (ODM). : There were 36 patients with YDM (23.6 ± 4.8 years) and 36 patients with ODM (54.3 ± 10.1 years) enrolled. Visfatin, RBP4, and MetS components were measured. The relationships between visfatin, RBP4 and MetS components were assessed in YDM and ODM. : The visfatin, but not the RPB4 level, was significantly higher in YDM than in ODM. After adjusting for age and body mass index, visfatin was not related to any MetS components except that there was a negative correlation with fasting plasma glucose (FPG). As for RPB4, triglyceride was found to be positively and FPG negatively related to RBP4 in YDM. However, in ODM, the only positive relationship that existed was between RBP4 and diastolic blood pressure. In conclusion, both visfatin and RBP4 had certain roles in diabetes and MetS although their relationships were different in YDM and ODM. Further studies are needed to explore their physiological and pathological effects in glucose metabolism.